Margarida Gonçalves graduated in Biochemistry, at the University of Aveiro. In 2013, she completed her Master Degree in Biochemistry (specialization in Clinical Biochemistry, University of Aveiro), where she presented her master thesis entitled Clinical relevance of the sialyl-Tn antigen in bladder cancer, developed at IPO-Porto, under the supervision of Dr. José Alexandre Ferreira. In continuity with her work in the Glycobiology field, she developed a BI fellowship at Instituto de Tecnologia Química e Biológica (ITQB), under the supervision of Dr. Júlia Costa, aiming to characterize deregulated glycoproteins on the cerebrospinal fluid and plasma from Amyotrophic Lateral Sclerosis (ALS) patients, as potential biomarkers for this disease.
In 2016, she joined the Cell Division & Genomic Stability Group (IBMC), to develop a BI fellowship under the supervision of Dr. Eurico Morais-de-Sá. Currently, she is a PhD student from the Molecular and Cellular Biology Program (IBMC/ICBAS). Her work aims to unravel the impact of several adhesion complexes in the robustness of epithelial cytokinesis, whose disruption underlies the development of epithelial cancers.